Appropriate surfactant usage in 1996

European Journal of Pediatrics, Supplement

Volumn 155, Issue 2, 1996, Pages

  Soll, R F ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Pneumothorax; Pulmonary surfactant; Respiratory distress syndrome

Indexed keywords

LUNG SURFACTANT; SURFACTANT;

BOLUS INJECTION; CONFERENCE PAPER; DRUG USE; EXTRACORPOREAL OXYGENATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG ALVEOLUS OXYGEN TENSION; NEWBORN INTENSIVE CARE; NONHUMAN; PNEUMOTHORAX; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SUBSTITUTION THERAPY; TREATMENT PLANNING;

ANIMALS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PNEUMOTHORAX; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0029836427     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Alvarado M, Hingre R, Hakason D, Gross S (1993) Clinical trial of Survanta versus Exosurf in infants < 1500 g with respiratory distress syndrome, Pediatr Res 33:314A
2. Dunn MS, Shennan AT, Possmayer F (1990) Single- versus multiple-dose surfactant replacement therapy in neonates at 30 to 36 weeks gestation with respiratory distress syndrome. Pediatrics 86:564-571
3. Dunn MS, Shennan AT, Zyack D, Possmayer F (1991) Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis vs treatment. Pediatrics 87:377-386
4. Egberts J, DeWinter JP, Sedin G et al. (1993) Comparison of prophylaxis and rescue treatment with Curosurf in babies less than 30 weeks gestation. Pediatrics 92:768-774